Showing 1,095 results

Filters Content type: News, Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Hepatitis C treatment

Pennsylvania to Offer Free Hepatitis C Treatment to Low-Income People With HIV

Editor's pick
Poz magazine news
5 February 2016
Activism & civil society

Lawsuits claim insurers unfairly refuse pricey hepatitis C drugs

Editor's pick
Seattle Times
3 February 2016
Hepatitis C treatment

Lawmaker: Costly hepatitis C drug "a slap in the face to veterans"

Editor's pick
CBS News
3 February 2016
Pharmaceutical industry

Merck Throws a Wrench in Drug Pricing

Editor's pick
Bloomberg
1 February 2016
New & experimental hepatitis C treatment

New Merck combination pill Zepatier approved for hepatitis C treatment in the United States

News
1 February 2016
Hepatitis C treatment

European Commission Approves Daklinza (daclatasvir) for the Treatment of Genotype 1, 3 and 4 Chronic Hepatitis C Patients with HIV Coinfection, Advanced Cirrhosis and Post-liver Transplant Recurrence of HCV

Editor's pick
Bristol-Myers Squibb press release
1 February 2016
Hepatitis C treatment

Merck Prices Hepatitis C Drug Lower Than Rivals in Crowded Field

Editor's pick
Bloomberg
29 January 2016
Hepatitis C treatment

California Doles Out Millions to Insurers for Hepatitis C Drugs

Editor's pick
KQED News
29 January 2016
Hepatitis C treatment

Kansas Legislators Walk Back On Lifetime Ban For Hepatitis C Drugs

Editor's pick
KCUR
24 January 2016
New & experimental hepatitis C treatment

AbbVie Initiates Enrollment of Six Global Phase 3 Clinical Studies for Once-Daily, Pan-Genotypic Hepatitis C Regimen

Editor's pick
AbbVie press release
11 January 2016
Hepatitis C treatment

The drug that costs more than $1200, and sells for $5 in India

Editor's pick
Sydney Morning Herald
3 January 2016
Hepatitis C treatment

DAAs could halt HCV epidemic in US – but only with near-universal testing and big increase in treatment rates

News
30 December 2015
Hepatitis C treatment

A quarter of people with HCV initially refused access to sofosbuvir/lepidasvir, says US study, but most successfully appeal

News
29 December 2015
Drug interactions & pharmacokinetics

Many patients on new HCV medications at risk of drug-drug interactions

Editor's pick
Medscape (requires free registration)
23 December 2015
Hepatitis C treatment

Australia: People Who Use Drugs Welcome Decision to ‘Seize the Day’ on New Hepatitis C Treatments

Editor's pick
Australian Injecting & Illicit Drug Users League
21 December 2015
Hepatitis C treatment

Concern over hepatitis C drug costs only the beginning, health officials say

Editor's pick
The News Tribune
21 December 2015
Hepatitis C treatment

Hopes Hepatitis C could be wiped out in Australia as the Federal Government pledges $1b to subsidise 'breakthrough' cures

Editor's pick
9news.com.au
21 December 2015
Access to healthcare

Sofosbuvir/daclatasvir combination could be produced for $200 per hepatitis C cure

News
14 December 2015
New & experimental hepatitis C treatment

Grazoprevir/elbasvir cures more than 90% of people with HIV/HCV co-infection

News
11 December 2015
Hepatitis C treatment

Study Probes Value of Hepatitis C Treatment at All Stages of Liver Fibrosis

Editor's pick
MD Magazine
10 December 2015
Hepatitis C treatment

European Physicians Report Strong but Variable Uptake of All-Oral Interferon-Free Hepatitis C Virus Regimens Across EU5 Countries

Editor's pick
Decision Resources press release
9 December 2015
Hepatitis C treatment

United States faces biggest burden of hepatitis C treatment costs before 2020

News
9 December 2015
Pharmaceutical industry

A New Look Behind the Pricing of a $1,000 Pill

Editor's pick
Open Society Foundations
8 December 2015
Finance & funding

The Impact Of New Hepatitis C Drugs On National Health Spending

Editor's pick
Health Affairs (blog)
8 December 2015